Cambridge Cognition wins multiple new contracts for virtual clinical trials
Cambridge Cognition has secured over $1.5 million in new contracts to support pharmaceutical clients in delivering virtual clinical trials
Cambridge Cognition has secured over $1.5 million in new contracts to support pharmaceutical clients in delivering virtual clinical trials
Discover the latest technologies and techniques that are revolutionizing 3D cell culture
Acquisition adds platform in gene variant interpretation based on next generation sequencing
Discover PAA’s new collaborative robot and interactive S-CEL laboratory workcell on booth 1313
Horizon’s reference standards supported assay development and subsequent clinical trial
Manchester start-up unveils world’s first microsphere nanoscope
Learn about advanced sequencing applications at the Wellcome Trust Centre for Human Genetics
Hydrogen now isn’t everything that hydrogen could be, writes Mats W. Lundberg, sustainable business manager at Sandvik Materials Technology
Smartphone-sized laboratory – Sepsis IVD grade test based on cutting-edge BioMEMS technology is a joint development objective
Dr. Carol Treasure discusses her hopes to accelerate the world’s transition to completely animal-free testing, to produce safe cosmetics and improve skin sensitization testing
Dr. Christian Regenbrecht discusses the power of patient-derived tumor organoids and their promising future in clinical practice
Dr. Ana de Oliveira from the Spatial Biology Core at UVA discusses the potential of the field to supercharge research across sectors
Leveraging the molecular insights derived from blood-based biomarkers creates a unique understanding of an individual's molecular health-state
Last month, more scientists than ever before left product reviews on SelectScience, helping up to 2 million peers around the world advance their own work
The tripartite mRNA technology has completed its phase 1b study for direct, intranodal injections in adjuvant melanoma patients